CurrentCurativePolicy CHP-IP-2026-012

Acute Myocarditis Inpatient Care

Customize your policy alerts

Sign up for curative Policy CHP-IP-2026-012 alerts

Get alerted when Policy CHP-IP-2026-012 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Medical-necessity criteria for acute inpatient admission, observation, level-of-care assignment, continued stay, and discharge readiness for Curative commercial PPO and EPO members with suspected or confirmed acute myocarditis.

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentCurativePolicy CHP-IP-2026-012

Acute Myocarditis Inpatient Care

Customize your policy alerts

Sign up for curative Policy CHP-IP-2026-012 alerts

Get alerted when Policy CHP-IP-2026-012 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerCurative

PolicyAcute Myocarditis Inpatient Care

Policy CodePolicy CHP-IP-2026-012

Change TypeNo material clinical or coverage changes

Effective DateN/A

Next Review DateN/A

Key ActionSubmit acute inpatient requests with at least one clinical severity finding and one hospital-level service requirement.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

All agesApplicable population

2-4 daysExpected length of stay

24 hoursContinued-stay review

50%High-risk ejection fraction threshold

≤30%ICU ejection fraction threshold

Medical Necessity and Level-of-Care Criteria

Inpatient admission

Acute inpatient admission for myocarditis is medically necessary when ALL of the following are met.

Clinical severity finding
- Reduced ventricular function or regional abnormality: New left ventricular ejection fraction below 50% or new regional wall motion abnormality.LVEF <50%
- Heart failure or shock: Heart failure symptoms or signs, or cardiogenic shock at SCAI stage C-E.SCAI stage C-E
- Electrical instability or syncope: Sustained or non-sustained ventricular tachycardia, high-grade atrioventricular block, or syncope.
- Ongoing ischemic-type concern: Rising troponin with ongoing chest pain or dynamic ECG changes.
- Specific myocarditis form suspected: Suspected immune checkpoint inhibitor, giant cell, or eosinophilic myocarditis.
Hospital-level service required
- Continuous ECG monitoring for arrhythmia.
- Intravenous cardiovascular therapy: Intravenous heart failure therapy, inotropes, or vasopressors.
- Temporary mechanical support: Temporary mechanical circulatory support, including intra-aortic balloon pump, microaxial flow pump, or veno-arterial ECMO.
- Biopsy and immunosuppression: Endomyocardial biopsy and high-dose immunosuppression for biopsy-proven or strongly suspected specific forms.
- Pacing or intravenous antiarrhythmic therapy: Temporary pacing or intravenous antiarrhythmic therapy.

Observation or outpatient instead of inpatient

Observation (24–48 hours) or outpatient care is appropriate when ANY of the following applies.

Observation or outpatient management

Observation for mild presentation: Suspected myocarditis with chest pain, mildly elevated troponin, preserved ejection fraction, no heart failure, and no arrhythmia on monitoring; use observation with troponin trend and echocardiography.LVEF >=50%; observation 24-48 hours
Outpatient follow-up after stabilization: Stable member with resolved symptoms, declining troponin, and preserved ejection fraction; arrange outpatient cardiac MRI and follow-up.

Intensive care unit

ICU care is medically necessary when ANY of the following is present.

ICU level of care

Fulminant myocarditis or shock: Fulminant myocarditis or cardiogenic shock requiring vasopressors, inotropes, or mechanical circulatory support.
Life-threatening arrhythmia or block: Sustained ventricular tachycardia, ventricular fibrillation, or complete heart block.
Severe ventricular dysfunction with compromise: Left ventricular ejection fraction of 30% or less with heart failure and hemodynamic compromise.LVEF <=30%
Respiratory failure requiring ventilation.

Step-down or intermediate care

Step-down care is medically necessary when no ICU criterion is met and ANY of the following is present.

Reduced function or non-sustained VT: Reduced ejection fraction or non-sustained ventricular tachycardia requiring continuous ECG monitoring.
Intravenous diuresis: Intravenous diuretics with frequent reassessment.
Early ongoing myocardial injury: Rising troponin or ongoing chest pain during the first 24–48 hours.24-48 hours

Medical-surgical unit

Medical-surgical care is appropriate when continued acute care is needed but no ICU or step-down criterion is met, including ANY of the following.

Medical-surgical acute care

Diagnostic evaluation: A stable member is completing in-hospital diagnostic evaluation needed to direct therapy, such as cardiac MRI or biopsy results.
Heart failure therapy initiation: Initiation of guideline-directed heart failure therapy with stable hemodynamics.

Discharge readiness

The member is ready for discharge when ALL of the following are met.

Clinical improvement: Troponin has declined for at least 24 hours and chest pain has resolved.Troponin declining >=24 hours
Stable function and support-free period: Ejection fraction is stable or improving, and no inotrope, vasopressor, or mechanical support has been required for at least 24 hours.No support >=24 hours
Arrhythmia stability: No hemodynamically significant arrhythmia has occurred for at least 48 hours.No significant arrhythmia >=48 hours

Continued-stay criteria

Continued acute inpatient stay is medically necessary, with review every 24 hours or every 12 hours in the ICU, when ANY of the following is documented.

Continued stay

Worsening function or shock: Ejection fraction is declining or cardiogenic shock is present.
New electrical instability: New or recurrent ventricular arrhythmia or conduction disease.
Mechanical support: Mechanical circulatory support is in place or being weaned.
Biopsy-directed treatment pending: Awaiting endomyocardial biopsy results that will change immunosuppressive therapy.

Isolated pericarditis is outside the scope of this acute myocarditis policy and is addressed under Policy A009.

Chronic inflammatory cardiomyopathy managed in the outpatient setting is outside the scope of this policy.

For Curative commercial plans, the Medicare two-midnight benchmark is not a coverage criterion. Expected length-of-stay benchmarks are used for planning and do not limit covered inpatient days.

Admission for suspected myocarditis does not meet medical-necessity criteria when the member has preserved ejection fraction, stable troponin, and no arrhythmia after observation. In this situation, outpatient follow-up and cardiac MRI are appropriate; the request is referred for physician review.

A continued inpatient stay solely to obtain cardiac MRI does not meet criteria when the member is stable and the MRI can be performed promptly as an outpatient. This represents the wrong site of care.

Days spent awaiting placement after discharge readiness has been established, without an ongoing acute need, are custodial days and do not meet acute-care criteria. The case should be referred for physician review and discharge planning.

Applicable Diagnosis, Procedure, and Billing Codes

ICD-10-CM acute myocarditisICD-10

I40.0	Acute myocarditis
I40.1	Acute myocarditis
I40.8	Acute myocarditis
I40.9	Acute myocarditis
I41	Acute myocarditis

ICD-10-PCS mechanical circulatory support examplesICD-10

5A02210	Mechanical circulatory support (example)
5A0221D	Mechanical circulatory support (example)
5A1522G	Mechanical circulatory support (example)

MS-DRG other circulatory system diagnosesMS-DRG

314	Other circulatory system diagnoses
315	Other circulatory system diagnoses
316	Other circulatory system diagnoses

MS-DRG heart failure and shockMS-DRG

291	Heart failure and shock
292	Heart failure and shock
293	Heart failure and shock

Revenue codesRevenue

0120	Revenue code
0200	Revenue code
0250	Revenue code
0300	Revenue code
0402	Revenue code
0610	Revenue code
0730	Revenue code

Ejection fraction thresholds

Preserved ejection fraction50% or higher

Reduced ejection fractionNew ejection fraction below 50% is a clinical severity finding

Additional severity findingA new regional wall motion abnormality also supports severity

ICU ejection fraction threshold

Severe thresholdLeft ventricular ejection fraction of 30% or less

Required associated finding

Authorization, Documentation, and Review Requirements

Prior Authorization

Inpatient Admission Authorization

Acute inpatient admission for myocarditis may be approved when both a clinical severity finding and a hospital-level service are documented. Suspected or confirmed myocarditis should be supported by troponin elevation plus compatible ECG, imaging, or MRI findings, with acute coronary syndrome excluded or deemed unlikely.

Clinical severity: At least one of new LVEF below 50% or regional wall-motion abnormality; heart-failure signs or symptoms or cardiogenic shock (SCAI stage C–E); sustained or nonsustained ventricular tachycardia, high-grade AV block, or syncope; rising troponin with ongoing chest pain or dynamic ECG changes; or suspected immune-checkpoint-inhibitor, giant-cell, or eosinophilic myocarditis.
Hospital-level service: At least one of continuous ECG monitoring; IV heart-failure therapy, inotropes, or vasopressors; temporary mechanical circulatory support; endomyocardial biopsy with high-dose immunosuppression for biopsy-proven or strongly suspected specific forms; or temporary pacing/IV antiarrhythmic therapy.

Prior Authorization

Concurrent Continued-Stay Review

Continued acute inpatient stay requires documented acute need and is reviewed every 24 hours, or every 12 hours in the ICU. Continued stay may be supported by declining ejection fraction or cardiogenic shock, new or recurrent ventricular arrhythmia or conduction disease, mechanical circulatory support in place or being weaned, pending biopsy results that will change immunosuppressive therapy, or ongoing IV heart-failure therapy.

Clinical Context

Acute myocarditis is evaluated using troponin, ECG, echocardiography, and cardiac MRI with updated Lake Louise criteria, which incorporate both T1- and T2-based markers. High-risk presentations include reduced ventricular function, heart failure, hemodynamic instability, sustained ventricular arrhythmia, and high-grade atrioventricular block. Fulminant cases and members requiring mechanical circulatory support may require transfer to a center with advanced heart failure and mechanical-support capability; members with mild presentations, preserved ventricular function, and no arrhythmia may be observed briefly.

Clinical Definitions and Risk Features

Myocarditis stage C

Clinical presentationSymptomatic myocarditis, such as chest pain, heart failure symptoms, or palpitations

Required evidenceEvidence of myocardial inflammation

Stage designationThis presentation is classified as myocarditis stage C

Myocarditis stage D

Stage designationMyocarditis stage D is advanced myocarditis

Instability featuresHemodynamic instability, cardiogenic shock, or electrical instability

Intervention requirement

Policy Summary

PayerCurative

PolicyAcute Myocarditis Inpatient Care

Policy CodePolicy CHP-IP-2026-012

Change TypeNo material clinical or coverage changes

Effective DateN/A

Next Review DateN/A

Key ActionSubmit acute inpatient requests with at least one clinical severity finding and one hospital-level service requirement.

SourceLink

On This Page

Treatment plans: Guideline-directed heart failure therapy has been started when ejection fraction is reduced, and an immunosuppression plan is documented for specific forms.

MRI plan: Cardiac MRI is completed or scheduled.

Defibrillator assessment: A wearable cardioverter-defibrillator has been considered when ejection fraction is 35% or less or a ventricular arrhythmia occurred, with reassessment planned.LVEF <=35% or ventricular arrhythmia

Exercise counseling: The member has been counseled to avoid competitive sports and strenuous exercise for 3–6 months, with return guided by ventricular function, rhythm monitoring, and biomarkers.3-6 months

Follow-up: Cardiology follow-up is arranged within 1–2 weeks.1-2 weeks

Intravenous heart failure therapy is still required.

ICU-level compromiseHemodynamic compromise; together these findings support ICU care

Observation duration

Observation duration24–48 hours

Appropriate presentationChest pain, mildly elevated troponin, preserved ejection fraction, no heart failure, and no arrhythmia on monitoring

Observation monitoringTroponin trend and echocardiography

Troponin trend before discharge

Minimum durationTroponin must be declining for at least 24 hours

Additional discharge conditionChest pain must be resolved

Clinical contextBoth conditions are part of discharge readiness

Arrhythmia-free monitoring

Minimum monitoring periodNo hemodynamically significant arrhythmia for at least 48 hours

Arrhythmia standardThe requirement concerns hemodynamically significant arrhythmia

Clinical contextThis is a discharge-readiness condition

Wearable cardioverter-defibrillator

Ejection fraction criterionConsider a wearable cardioverter-defibrillator when ejection fraction is 35% or less

Rhythm criterionAlso consider it when a ventricular arrhythmia has occurred

Follow-upReassessment should be planned

Expected stay is a planning benchmark only: uncomplicated myocarditis is about 2–4 days; fulminant myocarditis with mechanical support may require longer.
Extended-stay triggers include mechanical circulatory support, recurrent arrhythmia, biopsy-guided immunosuppression, and transplant or durable-support evaluation.
Days already authorized are not retroactively denied; the Medicare two-midnight benchmark is not a coverage criterion for these commercial plans.

Billing Rule

Partial Approval for Supported Care

When documentation supports only part of the requested care, approve the supported portion and separately address the excess increment. Concurrent review applies to each continued-stay period, and an expected length of stay does not limit covered days.

The requested quantity, units, or duration must be supported by the clinical documentation.
Only the unsupported increment is referred for review or denied; supported care remains eligible for approval.

Note

Reviewer Authority and Physician Escalation

Automated systems and non-physician clinical reviewers may approve a request in full or in part, but they may not issue an adverse determination. Requests that do not meet criteria must be referred for physician review.

Only a licensed physician of the same or similar specialty may issue an adverse determination.
The reviewing physician must offer the requesting provider a peer-to-peer discussion and meet applicable plan licensure, specialty, and medical-director requirements.

Documentation Required

Cardiac Assessment

Include the cardiac assessment supporting the request, including the troponin trend, ECG findings, and echocardiography results.

Document changes over time in troponin and relevant ECG findings.
Include echocardiographic ejection fraction and any regional wall-motion abnormality.

Documentation Required

Coronary Evaluation

Document coronary evaluation excluding acute coronary syndrome when indicated, particularly when myocarditis is being used to support inpatient care.

State the evaluation performed and whether acute coronary syndrome was excluded or deemed unlikely.

Documentation Required

Cardiac MRI

Provide cardiac MRI findings using updated Lake Louise criteria when MRI is performed. If MRI is deferred, document the clinical rationale for deferral.

Include the MRI interpretation and relevant Lake Louise findings.
Explain why MRI was deferred when it is not obtained.

Documentation Required

Endomyocardial Biopsy

When endomyocardial biopsy is performed, document the indication and the biopsy result, including how the result affects treatment when applicable.

For biopsy-guided immunosuppression, identify the suspected or confirmed specific form of myocarditis and the treatment implication.

Documentation Required

Exposure History

Document relevant exposure history, including recent viral illness, immune checkpoint inhibitor therapy, vaccination, and drug exposures.

Identify the exposure, timing, and any suspected relationship to the myocarditis presentation.
For suspected immune-checkpoint-inhibitor myocarditis, document therapy status and cardio-oncology involvement; the checkpoint inhibitor should be held and high-dose corticosteroids started promptly when clinically indicated.

Documentation Required

Daily Review and Discharge Plan

For each review day, document the level-of-care justification and an active discharge activity plan. The record should show why acute inpatient care remains necessary and what steps are underway for safe transition.

Include current clinical status, required monitoring or treatment, and any discharge barriers or follow-up arrangements.
Discharge planning should address activity guidance and appropriate outpatient cardiac follow-up.

Billing Rule

Support the Requested Extent of Service

Documentation must support the full requested extent of service, including quantity, units, and duration. If the record supports less than requested, the supported portion may be approved while the excess increment is reviewed.

Tie each requested service and increment to the patient's documented severity, treatment needs, and expected duration.

Denial Risk

Stable Suspected Myocarditis

Admission for suspected myocarditis does not meet acute inpatient criteria when ejection fraction is preserved, troponin is stable, and there is no arrhythmia after observation. Outpatient follow-up and cardiac MRI are appropriate in this stable scenario.

This request is not denied by an automated system or non-physician reviewer; it is referred for physician review.

Denial Risk

MRI-Only Continued Stay

A continued stay solely to obtain cardiac MRI for a stable member does not meet acute inpatient criteria when the MRI can be performed promptly as an outpatient. This is a wrong-site-of-care scenario and is referred for physician review.

Document any acute instability or other hospital-level need if inpatient MRI is being requested.

Unsupported block type: denial_risk

Denial Risk

Unsafe Discharge

Discharge is unsafe when there is arrhythmia, rising troponin, or clinical worsening. Continue acute care and document the active instability and required monitoring or treatment.

Hypotension, rising lactate, or falling ejection fraction may indicate a fulminant course requiring ICU transfer and early referral to a center with mechanical circulatory support and transplant capability.
Ventricular tachycardia, high-grade AV block, or syncope requires ICU monitoring, temporary pacing as needed, and evaluation for giant-cell myocarditis or sarcoidosis.

Prior Authorization

Physician Review Required for Adverse Determination

An adverse determination may be issued only after review by a licensed physician of the same or similar specialty, with an opportunity for the requesting provider to participate in a peer-to-peer discussion.

Automated and non-physician reviewers may approve in full or in part but may not issue an adverse determination.
The physician reviewer must satisfy applicable licensure, specialty, and medical-director requirements of the plan's situs state.

Billing Rule

Unsupported Quantity or Duration

When the documentation supports only part of a requested quantity or duration, approve the supported portion and review or deny only the unsupported excess. The absence of a criterion specifically addressing a service is not itself a basis for adverse determination; a physician must apply generally accepted standards of medical practice.

Document the quantity, units, and duration that are supported and identify the excess increment separately.
A procedure need not be on the CMS inpatient-only list; inclusion on that list supports approval of inpatient status.
Coverage remains subject to the member's benefit plan and applicable federal and state law.

Instability requiring intervention; includes fulminant myocarditis

Updated Lake Louise criteria

T2-based markerAt least one T2-based marker of edema

T1-based markerAt least one T1-based marker is also required

Examples of T1-based markersLate gadolinium enhancement, elevated native T1, or extracellular volume

High-risk features

Reduced ventricular functionLeft ventricular ejection fraction below 50%, especially 30% or less

Hemodynamic riskHeart failure or hemodynamic instability

Electrical riskSustained ventricular arrhythmia or high-grade atrioventricular block